CLRB Cellectar Biosciences, Inc.: institutional ownership and insider trading
30 funds reported holding $9.34M of Cellectar Biosciences, Inc. in their latest 13F filings; in Q2 2026 funds net bought $7.44M, with 13 new positions and 4 funds selling out; over the last 12 months insiders bought $50.0K and sold $733 on the open market.
Largest institutional holders of CLRB
- Caligan Partners LP — $1.31M
- STEMPOINT CAPITAL LP — $987K
- VANGUARD CAPITAL MANAGEMENT LLC — $910K
- SILVERARC CAPITAL MANAGEMENT, LLC — $894K
- Bleichroeder LP — $803K
- Jupiter Topco LLC — $759K
- BALYASNY ASSET MANAGEMENT L.P. — $612K
- Nantahala Capital Management, LLC — $612K
- Empery Asset Management, LP — $527K
- DIADEMA PARTNERS LP — $385K
Recent CLRB insider trades
- May 7, 2026: Caruso James V bought 8,680 shares ($25.0K)
- May 7, 2026: Longcor Jarrod bought 8,680 shares ($25.0K)
- Dec 12, 2025: Neis John sold 198 shares ($733)
- Jul 2, 2025: Caruso James V bought 10,000 shares ($49.9K)
5%+ owners
- Empery Asset Management, LP: 10.0% (Schedule 13G, filed Aug 4, 2026)
- JANUS HENDERSON GROUP PLC: 10.0% (Schedule 13G, filed Jun 5, 2026)
- SilverArc Capital Management, LLC: 10.0% (Schedule 13G, filed Aug 14, 2026)
- BALYASNY ASSET MANAGEMENT L.P.: 10.0% (Schedule 13G, filed Aug 14, 2026)
- Bleichroeder LP: 10.0% (Schedule 13G, filed Aug 13, 2026)
- StemPoint Capital LP: 9.9% (Schedule 13G, filed Aug 14, 2026)